References

  1. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012 May 26;379(9830):1960-6. PubMed | Google Scholar

  2. Tinto H, Bonkian LN, Nana LA, Yerbanga I, Lingani M, Kazienga A et al. Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change. Malar J. 2014 Jan;13:207. PubMed | Google Scholar

  3. Chandra RS, Orazem J, Ubben D, Duparc S, Robbins J, Vandenbroucke P. Creative solutions to extraordinary challenges in clinical trials: methodology of a phase III trial of azithromycin and chloroquine fixed-dose combination in pregnant women in Africa. Malar J. 2013 Apr 11;12:122. PubMed | Google Scholar

  4. Hand CC, Meshnick SR. Is chloroquine making a comeback? J Infect Dis. 2011 Jan 1;203(1):11-2. PubMed | Google Scholar

  5. Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. J Infect Dis. 2010 Sep 1;202(5):801-8. PubMed | Google Scholar

  6. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003 Jun 15;187(12):1870-5. PubMed | Google Scholar

  7. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G et al. Chloroquine resistance before and after its withdrawal in Kenya. Malar J. 2009 Jan;8:106. PubMed | Google Scholar

  8. Tinto H, Diallo S, Zongo I, Guiraud I, Valea I, Kazienga A et al. Effectiveness of artesunate-amodiaquine vs artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial. Trop Med Int Heal. 2007 Apr;19(4):469-75. PubMed | Google Scholar

  9. Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344(4):257-63. PubMed | Google Scholar

  10. Tinto H, Sanou B, Dujardin JC, Ouédraogo JB, Overmeir CVAN, Erhart A et al. Usefulness of the plasmodium falciparum chloroquine resistance transporter t76 genotype failure index for the estimation of in vivo chloroquine resistance in Burkina faso. Am J Trop Med Hyg. 2005;73(1):171-3. PubMed | Google Scholar

&